Archive for Tag: Bayer AG trade Ideas

Technical Analysis

BAYER AG: WEEKLY SCENARIO – 16 February 2022

BAYER AG Technical Analysis: Weekly Chart In the weekly charts, BAYER AG is trading in an up channel. It is trading above all SMA. The immediate support is 52.41 & the resistance level is at 55.25. BAYER AG is trading in the up channel until there is a trend...

Read More

Breaking up is not for us, Bayer CEO says

Bayer (OTC:BAYRY) is trading down 0.59% at 49.60 German drugs and pesticides maker Bayer (OTC:BAYRY)has no plans to split its three main businesses into separately traded companies, Chief Executive Werner Baumann said, amid a flurry of conglomerates moving to break themselves up. “We are going to continue the course,...

Read More

Bayer buys biopharma firm Vividion Therapeutics for up to $2 billion

Bayer AGis trading down 5.09% at 47.29 Bayer AG on Thursday said it acquired U.S.-based biopharmaceutical company Vividion Therapeutics for up to $2 billion to boost its ability to discover new treatments and lift the value of its drug pipeline. The deal, expected to close during the third quarter,...

Read More

Bayer says to appeal U.S. court ruling on PCBs if necessary

Bayer (OTC:BAYRY) is trading down 0.24% at 50.42 German chemicals maker Bayer (OTC:BAYRY)said on Wednesday it may appeal an order in a U.S. legal case to pay $185 million to four staff members of a school in the state of Washington over exposure to polychlorinated biphenyls, or PCBs, made...

Read More

Bayer hit by failure to cap risk from weedkiller cases

Bayer (OTC:BAYRY) is trading down 3.69% at 52.93 Bayer shares dropped as much as 5% on Thursday after a U.S. judge rejected its plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer. The German group called into question the future...

Read More

Judge suggests warning label as part of $2 billion plan to limit Roundup claims

Bayer AG (DE:BAYGN) DOWN 1.05% AT 16.95 A U.S. judge suggested on Wednesday that Bayer AG (DE:BAYGN) include a warning label on Roundup as part of a proposed $2 billion settlement to resolve future claims that the top-selling weedkiller causes cancer. Bayer (OTC:BAYRY) asked U.S. District Judge Vince Chhabria in...

Read More